The Recall Desk
CriticalFDA (Drugs)·D-1145-2016·Announced 2016-07-13

Prime Capsules Recalled for Undeclared Sibutramine and Phenolphthalein

Bee Extremely Amazed LLC is recalling Prime Capsules because they contain undeclared sibutramine and phenolphthalein, making them unapproved drugs.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 5 according to the rubric.

Plain-English summary

Bee Extremely Amazed LLC is recalling Prime Capsules, 500mg, 60-count bottles, distributed by Zagonfly. The recall involves 1,104 bottles distributed nationwide across all lots.

The product was marketed as a dietary supplement without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Testing revealed the product is tainted with undeclared sibutramine, an appetite suppressant previously withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient previously withdrawn due to concerns of carcinogenicity. These undeclared ingredients make the product an unapproved drug.

Consumers who purchased Prime Capsules should stop using the product and contact the distributor or manufacturer for further instructions.

The recalled product

Product
Prime Capsules, 500mg, 60-count bottles, Distributed By Zagonfly 3129 25th St. #392 Columbus, IN 47203
Affected units
1,104

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 14 recalled by Bee Extremely Amazed LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 14 products in this recall →